Toggle navigation
Login
Toggle navigation
View Item
DigitalGeorgetown Home
Bioethics Research Library of the Kennedy Institute of Ethics
Bioethics Literature and Resources
EthxWeb: Literature in Bioethics
View Item
DigitalGeorgetown Home
Bioethics Research Library of the Kennedy Institute of Ethics
Bioethics Literature and Resources
EthxWeb: Literature in Bioethics
View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.
Eli Lilly Pays Record Fines of $1.4bn for Promoting Off-Label Use of Olanzapine for Common Disorders
Creator
Kmietowicz, Zosia
Bibliographic Citation
BMJ:British Medical Journal 2009 January 24; 338(7688): 191
Permanent Link
Find in a Library
http://hdl.handle.net/10822/951940
Date
2009-01-24
Subject
Off-Label Use
;
Drugs and Drug Industry
;
Business Ethics
;
Collections
EthxWeb: Literature in Bioethics
Metadata
Show full item record
Related items
Showing items related by title, author, creator and subject.
Pfizer Agress to Pay Record Fine of $2.3 Billion for Promotion of Off-Label Use of Four Drugs
Tanne, Janice Hopkins
(
2009-09-12
)
Related Items in Google Scholar
Search DigitalGeorgetown
This Collection
Browse
All of DigitalGeorgetown
Communities & Collections
Creators
Titles
By Creation Date
This Collection
Creators
Titles
By Creation Date
My Account
Login
Statistics
View Usage Statistics
